SEC Form 4 · accession 0001104659-18-010411
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack A. Khattar
Officer — President, CEO · Director
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 449,944 | D | ||
| Common StockF2 | holding | — | — | — | 2,500 | I | By son | |
| Common Stock | holding | — | — | — | 1,089,750 | I | By the KBT Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $39.40 | Feb 14, 2018 | A | 250,000 | A | — | Feb 14, 2028 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1Includes an aggregate of 290 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
- F2The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
- F3The option vests in four equal annual installments beginning on February 14, 2019.